Related Experiment Video
Updated: May 12, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
Current state of endovascular treatment for vasculogenic erectile dysfunction
Femi Philip1, Mehdi H Shishehbor
1Department of Cardiovascular Medicine, Heart & Vascular Institute, Cleveland Clinic, 9500 Euclid Avenue, J3-05, Cleveland, OH, 44195, USA. philipf@ccf.org
Abstract:
Normal erectile function requires adequate penile arterial inflow, normal penile architecture and an intact venous capacitance system. Vascular disease is the dominant etiology of erectile dysfunction (ED) and current medical therapy increases penile blood flow. However, in a large proportion of patients, medical therapy is inadequate or contraindicated requiring the use of mechanical constrictive devices or implantation of a penile prosthesis. Rapid advances in endovascular intervention have allowed safe and effective treatment of small arteries in other vascular beds. A minimally invasive approach targeting penile arterial inflow disease may prove to be safe and effective. In this paper, we discuss the normal arterial blood supply to the penis, describe angiographic findings in patients with ED, and critically review the published data on endovascular and microsurgical approaches at reestablishing penile blood flow. Lastly, we offer a potential algorithm and procedural tips for endovascular intervention for ED.
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Peripheral Artery Disease III: Interprofessional Care
Venous Thrombosis III: Interprofessional Care
Varicose Veins II: Diagnostic Studies and Interprofessional Care
